Skip to main content
SpringerLink
Log in

Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The purpose of this study was to evaluate the prevalence and clinical risk factors for quinolone resistance (QR) in E. coli strains from males with febrile urinary tract infection (FUTI). An ambispective cross-sectional study was performed in which we evaluated 153 males with a community FUTI caused by E. coli. Among the 153 FUTI episodes, 101 (66%) were due to quinolone susceptible E. coli strains while 52 (34%) were caused by QR E. coli strains. In the univariate analysis QR was associated with older age, higher Charlson scores, dementia, past UTI, urinary tract abnormalities, previous antibiotic use, particularly with fluoroquinolones (FQ), a healthcare-associated (HA)-UTI (HA-UTI) and to four of the components included in the definition of HA-UTI: hospital admission, nursing home residence, indwelling urethral catheter and invasive urinary instrumentation. In the multivariate analysis, HA-UTI (OR 3.82, 95% CI 1.3–11.24; P 0.015) and use of antimicrobials in the previous month (OR 5.82, 95% CI 2.3–14.88; P < 0.001) mainly with FQ (OR 13.97, 95% CI 2.73–71.53; P 0.002) were associated with QR. To have a HA-UTI and a previous use of FQ in the preceding month were strong risk factors for QR E. coli, and thus empirical antimicrobial treatment with quinolones should be avoided in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ulleryd P (2003) Febrile urinary tract infection in men. Int J Antimicrob Agents 22(Suppl 2):89–93

    Article  PubMed  Google Scholar 

  2. Horcajada JP, Vilana R, Moreno-Martínez A, Alvarez-Vijande R, Bru C, Bargallo X, Buñesch L, Martinez JA, Mensa J (2003) Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications. Scand J Infect Dis 35:114–120

    Article  PubMed  Google Scholar 

  3. Velasco M, Mateos JJ, Martínez JA, Moreno-Martinez A, Horcajada JP, Barranco M, Lomeña F, Mensa J (2004) Accurate topographical diagnosis of urinary tract infection in male patients with (111) indium-labelled leukocyte scintigraphy. Eur J Intern Med 15:157–161

    Article  PubMed  Google Scholar 

  4. Krieger JN, Nyberg L, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282:236–237

    Article  PubMed  CAS  Google Scholar 

  5. Naber KG, Sörgel F (2003) Antibiotic therapy: rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and prostatic tissue. Andrologia 35:331–335

    PubMed  CAS  Google Scholar 

  6. Johnson L, Sabel A, Burman WJ, Everhart RM, Rome M, MacKenzie TD, Rozwadowski J, Mehler PS, Price CS (2008) Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 121:876–884

    Article  PubMed  CAS  Google Scholar 

  7. European Centre for Disease Prevention and Control (2010) Antimicrobial resistance surveillance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)2009. Available at: http://www.ecdc.europa.eu/en/publications/Publications/1011_SUR_annual_EARS_Net_2009.pdf. Accessed 6 January 2011

  8. Killgore KM, March KL, Guglielmo BJ (2004) Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother 38:1148–1152

    Article  PubMed  CAS  Google Scholar 

  9. Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group (2005) Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 56:914–918

    Article  PubMed  CAS  Google Scholar 

  10. Colodner R, Kometiani I, Chazan B, Raz R (2008) Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection 36:41–45

    Article  PubMed  CAS  Google Scholar 

  11. Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, Strom BL (2002) Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med 162:2469–2477

    Article  PubMed  Google Scholar 

  12. Etienne M, Chavanet P, Sibert L, Michel F, Levesque H, Lorcerie B, Doucet J, Pfitzenmeyer P, Caron F (2008) Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis 30:8–12

    Google Scholar 

  13. Khawcharoenporn T, Vasoo S, Ward E, Singh K (2010) High rates of quinolone resistance among urinary tract infections in the ED. Am J Emerg Med. doi:10.1016/j.ajem.2010.09.030, Epub ahead of print

  14. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797

    PubMed  Google Scholar 

  15. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method for classifying comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  PubMed  CAS  Google Scholar 

  16. Lipsky BA, Ireton RC, Fihn SD, Hackett R, Berger RE (1987) Diagnosis of bacteriuria in men: specimen collection and culture interpretation. J Infect Dis 155:847–854

    Article  PubMed  CAS  Google Scholar 

  17. CLSI (2007) Performance Standards for antimicrobial susceptibility testing: 17th informational supplement. CLSI document M100S17. Clinical and Laboratory Standard Institute, Wayne, PA

    Google Scholar 

  18. Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A (2008) Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 168:1897–1902

    Article  PubMed  Google Scholar 

  19. Velasco M, Horcajada JP, Mensa J, Mensa J, Moreno-Martinez A, Vila J, Martinez JA, Ruiz J, Barranco M, Roig G, Soriano E (2001) Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 33:1682–1686

    Article  PubMed  CAS  Google Scholar 

  20. Alos JI, Serrano MG, Gomez-Garces JL, Perianes J (2005) Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect 11:199–203

    Article  PubMed  CAS  Google Scholar 

  21. Koeijers JJ, Verbon A, Kessels AG, Bartelds A, Donkers G, Nys S, Stobberingh EE (2010) Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 76:336–340

    Article  PubMed  CAS  Google Scholar 

  22. Lautenbach E, Metlay JP, Mao X, Han X, Fishman NO, Bilker WB, Tolomeo P, Wheeler M, Nachamkin I (2010) The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis 51:280–285

    Article  PubMed  CAS  Google Scholar 

  23. Hawkey PM (2003) Mechanisms of quinolone action and microbial response. J Antimicrob Chemother 51(Suppl 1):29–35

    Article  PubMed  CAS  Google Scholar 

  24. Tavio MM, Vila J, Ruiz J, Martin-Sanchez AM, Jimenez de Anta MT (1999) Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli. J Antimicrob Chemother 44:735–742

    Article  PubMed  CAS  Google Scholar 

  25. Poole K (2000) Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria. Antimicrob Agents Chemother 44:2233–2241

    Article  PubMed  CAS  Google Scholar 

  26. Poirel L, Cattoir V, Nordmann P (2008) Is plasmid-mediated quinolone resistance a clinically significant problem? Clin Microbiol Infect 14:295–297

    Article  PubMed  CAS  Google Scholar 

  27. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD (2010) Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 340:c2096. doi:10.1136/bmj.c2096

    Article  PubMed  Google Scholar 

  28. Horcajada JP, Vila J, Moreno-Martínez A, Ruiz J, Martínez JA, Sánchez M, Soriano E, Mensa J (2002) Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis. J Antimicrob Chemother 49:55–59

    Article  PubMed  CAS  Google Scholar 

  29. Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O’Bryan TT, Sandberg T (2005) Phylogenetic and pathotypic comparison of concurrent urine and rectal Escherichia coli isolates from men with febrile urinary tract infection. J Clin Microbiol 43:3895–3900

    Article  PubMed  CAS  Google Scholar 

  30. Mazzoli S (2010) Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol Med Microbiol 59:337–344

    PubMed  CAS  Google Scholar 

  31. Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K, Misra A (2005) Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect Dis 5:37

    Article  PubMed  Google Scholar 

  32. Ruiz J, Gomez J, Navia MM, Ribera A, Sierra JM, Marco F, Mensa J, Vila J (2002) High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae. Diagn Microbiol Infect Dis 42:257–261

    Article  PubMed  CAS  Google Scholar 

  33. Grabe M, Bishop MC, Bjerklund-Johansen TE, Botto H, Çek M, Lobel B, Naber KG, Palou J, Tenke P, Wagenlehner F (2009) Guidelines on urological infections. European Association of Urology 2009. Available at http://www.uroweb.org/fileadmin/tx_eauguidelines/2009/Full/Urological_Infections.pdf. Accessed February 2011

Download references

Conflicts of interest

None to declare.

Author information

Authors and Affiliations

  1. Emergency Department, Fundació Hospital de l´Esperit Sant, C/Avinguda Mossen Pons i Rabadà s/n, 08923, Santa Coloma Gramenet, Barcelona, Spain

    A. Smithson & C. Netto

  2. Internal Medicine Department, Fundació Hospital de l’Esperit Sant, Santa Coloma de Gramenet, Barcelona, Spain

    C. Chico, J. Ramos, M. Sanchez, J. Ruiz & R. Porron

  3. Microbiology Laboratory, Fundació Hospital de l’Esperit Sant, Santa Coloma de Gramenet, Barcelona, Spain

    M. T. Bastida

Authors
  1. A. Smithson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Chico
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Ramos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Netto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Sanchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Ruiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Porron
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. T. Bastida
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Smithson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smithson, A., Chico, C., Ramos, J. et al. Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection. Eur J Clin Microbiol Infect Dis 31, 423–430 (2012). https://doi.org/10.1007/s10096-011-1322-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-011-1322-y

Keywords

Search

Navigation